Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | F2 | P00734 | 3/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.55 |
| ▸ | EDNRA | P25101 | 8/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NSD2 | O96028 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6416698 | 0.88 | CA2 (0.57) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL3806560 | 0.86 | CYP1A2 (0.63) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL13274117 | 0.85 | CYP1A2 (0.71) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL7558145 | 0.84 | CA2 (0.59) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL1861706 | 0.84 | CA2 (0.59) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL472152 | 0.84 | CA2 (0.63) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL2219412 | 0.82 | CA2 (0.61) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL16097557 | 0.82 | CYP1A2 (0.58) | CA2CYP1A2CYP2C19HTTHIF1A | |
| Trifluoroacetic Acid SCHEMBL1164011 | 0.82 | CA2 (0.50) | CA2CYP1A2CYP2C19HTTHIF1A | |
| SCHEMBL30363570 | 0.81 | EDNRA (0.56) | CA2CYP1A2CYP2C19HTTHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2496262-A2 | STABILIZED PROTEIN FORMULATIONS AND USE THEREOF | Université de Genève (CH) | 2012-09-12 | — | — | EP | disclosed |
| US-20120219538-A1 | STABILIZED PROTEIN FORMULATIONS AND USE THEREOF | THERAPEOMIC AG (CH) | 2012-08-30 | — | — | US | disclosed |
| WO-2011051916-A2 | STABILIZED PROTEIN FORMULATIONS AND USE THEREOF | UNIVERSITE DE GENEVE (CH) | 2011-05-05 | — | — | WO | disclosed |
| US-4378500-A | LIQUID CHROMATOGRAPHY WITH POLAR SOLVENT | VARIAN ASSOCIATES, INC. (US) | 1983-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120219538-A1 | STABILIZED PROTEIN FORMULATIONS AND USE THEREOF | TTR, ALB, CRYZ | CA2 4252/4885CYP1A2 4683/4885CYP2C19 4547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.